Your session is about to expire
← Back to Search
Active for Erectile Dysfunction
Study Summary
This trial is investigating whether Low-Intensity shock wave therapy (LiSWT) is a safe and effective treatment for patients who are experiencing erectile dysfunction (ED) after undergoing radical prostatectomy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do I meet the necessary criteria to participate in this medical study?
"To be eligible for this research study, individuals must have a diagnosis of erectile dysfunction and fall within the age range of 45 to 70 years old. The trial aims to recruit a total of 100 participants."
Are there any current opportunities for potential participants to enroll in this trial?
"Indeed, as per the details available on clinicaltrials.gov, this trial is currently seeking eligible participants. The initial posting of the study was made on January 10th, 2024, and it underwent its most recent update on January 19th, 2024."
What is the current number of participants being admitted into this clinical study?
"Indeed, clinicaltrials.gov confirms that this ongoing clinical trial is actively seeking individuals to participate. The initial posting of the trial took place on January 10th, 2024, and it was most recently updated on January 19th, 2024. The study aims to recruit a total of 100 participants from one designated location."
Does this medical study include the participation of individuals who have surpassed their 85th year?
"For this particular clinical trial, potential participants must be within the age range of 45 to 70. It is important to note that there are separate clinical trials available for individuals under the age of 18 (consisting of three trials) and those over the age of 65 (comprising a total of sixty trials)."
Share this study with friends
Copy Link
Messenger